ReviewJournal of thoracic disease2014
Improving radiotherapy planning, delivery accuracy, and normal tissue sparing using cutting edge technologies.
Review in Journal of thoracic disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Signal-aware deep learning-based respiratory motion prediction for lung tumor management.Frontiers in oncology · 2026Article
- A novel internal target volume definition based on velocity and time of respiratory target motion for external beam radiotherapy.Radiological physics and technology · 2024Article
- Four-dimensional treatment planning strategies for dynamic tumor tracking.Journal of applied clinical medical physics · 2024Article
- Translation regulatory long non-coding RNA 1 negatively regulates cell radiosensitivity via the miR-22-3p/SP1 axis in non-small cell lung cancer.The clinical respiratory journal · 2024Article
- A standardized workflow for respiratory-gated motion management decision-making.Journal of applied clinical medical physics · 2022Article
- Four-dimensional dose calculations for dynamic tumour tracking with a gimbal-mounted linear accelerator.Journal of applied clinical medical physics · 2021Article
- Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.International journal of radiation oncology, biology, physics · 2021Review
- Gated Radiotherapy Development and its Expansion.Journal of biomedical physics & engineering · 2021Article
- Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC).Scientific reports · 2021Article
- Dose measurements in a thorax phantom at 3DCRT breast radiation therapy.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2021Article
- Practical implications to contemplate when considering radical therapy for stage III non-small-cell lung cancer.British journal of cancer · 2020Review
- The Importance of Respiratory Rate Monitoring: From Healthcare to Sport and Exercise.Sensors (Basel, Switzerland) · 2020Review
- Enhancement of Radiosensitivity by Eurycomalactone in Human NSCLC Cells Through G₂/M Cell Cycle Arrest and Delayed DNA Double-Strand Break Repair.Oncology research · 2020Article
- Preclinical models of radiation-induced lung damage: challenges and opportunities for small animal radiotherapy.The British journal of radiology · 2019Review
- Impact of a novel exponential weighted 4DCT reconstruction algorithm.Journal of applied clinical medical physics · 2018Article
- Abscopal effect of radiation on bone metastases of breast cancer: A case report.Cancer biology & therapy · 2018Article
- Radiation Matters of the Heart: A Mini Review.Frontiers in cardiovascular medicine · 2018Review
- Treatment-Related Adverse Effects in Lung Cancer Patients after Stereotactic Ablative Radiation Therapy.Journal of oncology · 2018Review
- Inversed-Planned Respiratory Phase Gating in Lung Conformal Radiation Therapy.International journal of radiation oncology, biology, physics · 2017Article
- Optimizing tumor immune response through combination of radiation and immunotherapy.Medical oncology (Northwood, London, England) · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the United States, more than half of all new invasive cancers diagnosed are non-small cell lung cancer, with a significant number of these cases presenting at locally advanced stages, resulting in about one-third of all cancer deaths. While the advent of stereotactic ablative radiation therapy (SABR, also known as stereotactic body radiotherapy, or SBRT) for early-staged patients has improved local tumor control to >90%, survival results for locally advanced stage lung cancer remain grim. Significant challenges exist in lung cancer radiation therapy including tumor motion, accurate dose calculation in low density media, limiting dose to nearby organs at risk, and changing anatomy over the treatment course. However, many recent technological advancements have been introduced that can meet these challenges, including four-dimensional computed tomography (4DCT) and volumetric cone-beam computed tomography (CBCT) to enable more accurate target definition and precise tumor localization during radiation, respectively. In addition, advances in dose calculation algorithms have allowed for more accurate dosimetry in heterogeneous media, and intensity modulated and arc delivery techniques can help spare organs at risk. New delivery approaches, such as tumor tracking and gating, offer additional potential for further reducing target margins. Image-guided adaptive radiation therapy (IGART) introduces the potential for individualized plan adaptation based on imaging feedback, including bulky residual disease, tumor progression, and physiological changes that occur during the treatment course. This review provides an overview of the current state of the art technology for lung cancer volume definition, treatment planning, localization, and treatment plan adaptation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.